The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01610934
Recruitment Status : Completed
First Posted : June 4, 2012
Last Update Posted : September 5, 2013
Novo Nordisk A/S
University of Copenhagen
Information provided by (Responsible Party):
Signe H Østoft, MD, University Hospital, Gentofte, Copenhagen

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2013
  Actual Study Completion Date : August 2013